73 related articles for article (PubMed ID: 16110477)
21. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
[TBL] [Abstract][Full Text] [Related]
22. The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading.
Koch A; Mancini A; El Bounkari O; Tamura T
Oncogene; 2005 May; 24(21):3436-47. PubMed ID: 15735664
[TBL] [Abstract][Full Text] [Related]
23. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
Hurst JH; Henkel PA; Brown AL; Hooks SB
Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory role of polyunsaturated fatty acids on lysophosphatidic acid-induced cancer cell migration and adhesion.
Kim EK; Ha JM; Kim YW; Jin SY; Ha HK; Bae SS
FEBS Lett; 2014 Aug; 588(17):2971-7. PubMed ID: 24911199
[TBL] [Abstract][Full Text] [Related]
25. Lysophosphatidic acid modulates the regenerative responses of human gingival fibroblasts and enhances the actions of platelet-derived growth factor.
Cerutis DR; Dreyer A; Cordini F; McVaney TP; Mattson JS; Parrish LC; Romito L; Huebner GR; Jabro M
J Periodontol; 2004 Feb; 75(2):297-305. PubMed ID: 15068119
[TBL] [Abstract][Full Text] [Related]
26. Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.
So J; Navari J; Wang FQ; Fishman DA
Gynecol Oncol; 2004 Nov; 95(2):314-22. PubMed ID: 15491751
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
Symowicz J; Adley BP; Woo MM; Auersperg N; Hudson LG; Stack MS
Cancer Res; 2005 Mar; 65(6):2234-42. PubMed ID: 15781636
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
[TBL] [Abstract][Full Text] [Related]
29. S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells.
Smicun Y; Gil O; Devine K; Fishman DA
Gynecol Oncol; 2007 Nov; 107(2):298-309. PubMed ID: 17716713
[TBL] [Abstract][Full Text] [Related]
30. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
Do TV; Symowicz JC; Berman DM; Liotta LA; Petricoin EF; Stack MS; Fishman DA
Mol Cancer Res; 2007 Feb; 5(2):121-31. PubMed ID: 17314270
[TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidic acid promotes cell invasion by up-regulating the urokinase-type plasminogen activator receptor in human gastric cancer cells.
Kim MH; Park JS; Chang HJ; Baek MK; Kim HR; Shin BA; Ahn BW; Jung YD
J Cell Biochem; 2008 Jun; 104(3):1102-12. PubMed ID: 18247343
[TBL] [Abstract][Full Text] [Related]
32. Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites.
Sako A; Kitayama J; Shida D; Suzuki R; Sakai T; Ohta H; Nagawa H
J Surg Res; 2006 Jan; 130(1):94-101. PubMed ID: 16171822
[TBL] [Abstract][Full Text] [Related]
33. Melanoma cells break down LPA to establish local gradients that drive chemotactic dispersal.
Muinonen-Martin AJ; Susanto O; Zhang Q; Smethurst E; Faller WJ; Veltman DM; Kalna G; Lindsay C; Bennett DC; Sansom OJ; Herd R; Jones R; Machesky LM; Wakelam MJ; Knecht DA; Insall RH
PLoS Biol; 2014 Oct; 12(10):e1001966. PubMed ID: 25313567
[TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidic Acid Upregulates Laminin-332 Expression during A431 Cell Colony Dispersal.
Yamashita H; Tripathi M; Jourquin J; Kam Y; Liu S; Weidow B; Quaranta V
J Oncol; 2010; 2010():. PubMed ID: 20862207
[TBL] [Abstract][Full Text] [Related]
35. Diverse roles of LPA signaling in the intestinal epithelium.
Yun CC; Kumar A
Exp Cell Res; 2015 May; 333(2):201-207. PubMed ID: 25433271
[TBL] [Abstract][Full Text] [Related]
36. Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression.
Weiger MC; Vedham V; Stuelten CH; Shou K; Herrera M; Sato M; Losert W; Parent CA
PLoS One; 2013; 8(3):e58859. PubMed ID: 23527039
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells.
Tamm I; Cardinale I; Krueger J; Murphy JS; May LT; Sehgal PB
J Exp Med; 1989 Nov; 170(5):1649-69. PubMed ID: 2553849
[TBL] [Abstract][Full Text] [Related]
38. Signalling properties of lysophosphatidic acid.
Durieux ME; Lynch KR
Trends Pharmacol Sci; 1993 Jun; 14(6):249-54. PubMed ID: 8372406
[TBL] [Abstract][Full Text] [Related]
39. In vivo collective cell migration requires an LPAR2-dependent increase in tissue fluidity.
Kuriyama S; Theveneau E; Benedetto A; Parsons M; Tanaka M; Charras G; Kabla A; Mayor R
J Cell Biol; 2014 Jul; 206(1):113-27. PubMed ID: 25002680
[TBL] [Abstract][Full Text] [Related]
40. Moving in and Out: Dispersion of Cells in Self-Generated Gradients.
Stuelten CH
J Clin Cell Immunol; 2017 Jun; 8(3):. PubMed ID: 28868205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
